Mechanistic insights into TNFR1/MADD death domains in Alzheimer’s disease through conformational molecular dynamic analysis

Abstract

Proteins are tiny players involved in the activation and deactivation of multiple signaling cascades through interactions in cells. The TNFR1 and MADD interact with each other and mediate downstream protein signaling pathways which cause neuronal cell death and Alzheimer’s disease. In the current study, a molecular docking approach was employed to explore the interactive behavior of TNFR1 and MADD proteins and their role in the activation of downstream signaling pathways. The computational sequential and structural conformational results revealed that Asp400, Arg58, Arg59 were common residues of TNFR1 and MADD which are involved in the activation of downstream signaling pathways. Aspartic acid in negatively charged residues is involved in the biosynthesis of protein. However, arginine is a positively charged residue with the potential to interact with oppositely charged amino acids. Furthermore, our molecular dynamic simulation results also ensured the stability of the backbone of TNFR1 and MADD death domains (DDs) in binding interactions. This DDs interaction mediates some conformational changes in TNFR1 which leads to the activation of mediators proteins in the cellular signaling pathways. Taken together, a better understanding of TNFR1 and MADD receptors and their activated signaling cascade may help treat Alzheimer’s disease. The death domains of TNFR1 and MADD could be used as a novel pharmacological target for the treatment of Alzheimer’s disease by inhibiting the MAPK pathway.

Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies

“…Molecular docking is a computational approach used to predict the binding conformational behavior of biomolecules, i.e., drugs and proteins. − All of the screened drugs were docked and analyzed based on binding affinity (kcal/mol) (see the Supplementary Data S2). From docking results, it has been observed that from 100 FDA-approved drugs, 24 drugs showed binding affinity values higher than −7 kcal/mol and may have good binding potential inside the binding pocket of the EWS protein.…”

Decoding the genetic relationship between Alzheimer’s disease and type 2 diabetes: potential risk variants and future direction for North Africa

“…Annotation of the 231 shared SNPs showed that MADD and EFCAB5 harbored the highest number of these variants (nine SNPs). MADD gene, also known as IG20 , plays a critical role in the development of glucose intolerance ( Dupuis et al, 2010 ; Hu et al, 2010 ; Strawbridge et al, 2011 ; Wagner et al, 2011 ) and AD ( Del Villar and Miller, 2004 ; Hassan et al, 2021 ). In accordance with our findings, a large-scale genome-wide cross-trait study identified MADD as the only gene significantly associated with AD and fasting glucose exclusively in pituitary tissue; it is also the only shared gene found in both cross-trait Meta-analysis and Transcriptomic-wide association studies.…”

Prediction of Site Directed miRNAs as Key Players of Transcriptional Regulators Against Influenza C Virus Infection Through Computational Approaches

“…Molecular docking is a computational approach usually employed to check the binding potential of biomolecules (Hassan et al, 2022(Hassan et al, , 2021. The modelled 3D structures of hsa-miRNA-3155a and mRNA were docked to analyze the binding potential and nucleotide region involved in the binding conformations.…”